Frontlight ResearchEarly access
Trial site
VIN - Aventura
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Lewy body dementia1 trial
- Migraine1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Pfizer1 trial
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Lewy body dementia1 recruiting
- Migraine1 recruiting
- Mild cognitive impairment1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026